MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'dyskinesia'. Sat, 03 Sep 2011 02:50:10 +0100 http://www.medworm.com/index.php?rid=4968912&cid=t_140309_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FK90Sx9ix8RI%2F In a closely watched case, the US Supreme Court has ruled that generic drugmakers are not required to strengthen product labeling if alerted to side effects, even when the same change has not been made to the labeling for the branded med. However, the court was divided with a 5-to-4 majority deciding in favor of the argument made by the generic industry. The decision came in response to a pair of lawsuits by two women who claimed such changes could have been made under state law and without FDA approval for such changes. They argued generic drugmakers would create uncertainty about safety if they are not held liable under state laws and update labeling in the face of evidence of serious side effects. Generic drugmakers, including Actavis and Pliva, argued they would have been required to p... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4968912 Thu, 23 Jun 2011 15:16:43 +0100 4968912 http://www.medworm.com/index.php?rid=4747838&cid=t_140309_136_f&fid=39016&url=http%3A%2F%2Fturquoisegates.blogspot.com%2F2011%2F04%2Fcross-amidst-crisis.html Making choices about memory, being mindful about your thoughts. This is a new practice for me, and I wear it like a new outfit, fidgety and not sure how it looks on me. I watched the Passion of the Christ on Holy Saturday, and I was reminded, as Satan floated in and out Jesus' view, always with a half-smile on the face and the temptation to the easy route out, that in this way, also, I must follow my King. See Satan. But let Satan have no place in my thoughts. Flashbacks come, like Satan, flitting through the background of real life. But that's what they are, just flashbacks, just bad memories. The reality is that I am hidden in Christ, and I must see Satan flitting with His eyes, the eyes that looked calmly yet with dread toward His own day of suffering.I spend a week with friends and see... Turquoise Gates blogs http://www.medworm.com/rss/comments.php?id=4747838 Mon, 25 Apr 2011 09:59:00 +0100 4747838 http://www.medworm.com/index.php?rid=4302276&cid=t_140309_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2010%2F12%2Fbook-of-year-person-of-year-robert.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=4302276 Sat, 01 Jan 2011 04:55:00 +0100 4302276 http://www.medworm.com/index.php?rid=4134262&cid=t_140309_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FCFmHgENNk4s%2F The Obama administration is urging the US Supreme Court not to hear an appeal from several generic drugmakers that claim federal law preempts a product-liability lawsuit charging they failed to provide adequate risk information in their product labeling. The position was disclosed in this amicus brief filed by the US Solicitor General. Here’s the backdrop: several generic drugmakers want to preempt a lawsuit brought by Gladys Mensing, a Minnesota woman who took a version of Wyeth’s Reglan heartburn med and developed a neurological disorder known as tardive dyskinesia, which causes involuntary muscle movements (the lawsuit). The drugmakers won a trial, but lost on appeal and want the US Supreme Court to decide the matter. Last May, the Supreme Court has asked the US Solicitor Genera... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4134262 Wed, 03 Nov 2010 14:00:03 +0100 4134262 http://www.medworm.com/index.php?rid=4003416&cid=t_140309_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2010%2F09%2Fone-million-us-kids-on-antipsychotics.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=4003416 Mon, 27 Sep 2010 15:54:00 +0100 4003416 http://www.medworm.com/index.php?rid=4003075&cid=t_140309_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2010%2F09%2Fdoctors-letters-to-robert-whitaker.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=4003075 Sun, 26 Sep 2010 19:26:00 +0100 4003075 http://www.medworm.com/index.php?rid=4003076&cid=t_140309_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2010%2F09%2Fcoming-off-medications-workshop.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=4003076 Sun, 26 Sep 2010 15:45:00 +0100 4003076 http://www.medworm.com/index.php?rid=3595893&cid=t_140309_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FVV0SI3kd3zg%2F The preemption debate is not yet over. Several generic drugmakers want to preempt a product liability lawsuit brought by Gladys Mensing, a Minnesota woman who took a version of Wyeth’s Reglan heartburn med and developed a neurological disorder known as tardive dyskinesia, which causes involuntary muscle movements (the lawsuit). The drugmakers won a trial, but lost on appeal and want the US Supreme Court to decide the matter. So the Supreme Court has asked the US Solicitor General for its views on whether generic drugmaker can be sued over allegations that they failed to provide adequate risk information in their product labeling (see this). The drugmakers, which include Teva Pharmaceutical and Mylan’s UDL Laboratories, claim federal law preempts the lawsuit because it would req... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3595893 Tue, 25 May 2010 12:48:04 +0100 3595893 http://www.medworm.com/index.php?rid=1603089&cid=t_140309_122_f&fid=35055&url=http%3A%2F%2Fsarasotaneurology.com%2F2008%2F07%2F10%2Fparkinson-disease-may-benefit-from-early-brain-stimulation%2F Recent studies have suggested that qualifying Parkinson patients benefit from earlier treatment with deep brain stimulation, as reported in Clinical Neurology News. The study indicates that younger Parkinson disease patients are more likely to benefit from early brain stimulator treatment. There is information that may suggest that this therapy may have a protective effect in delaying the progression of Parkinson’s disease. Deep brain stimulation (DBS) was FDA approved in 2002 for treatment of Parkinson’s disease. Symptoms that are best controlled include tremor and dyskinesias although brain stimulation can also help reduce freezing and off time. Younger Parkinson patients develop motor complications such as dyskinesias, off time and freezing much earlier than older patients w... Sarasota Neurology blogs http://www.medworm.com/rss/comments.php?id=1603089 Thu, 10 Jul 2008 10:00:33 +0100 1603089 http://www.medworm.com/index.php?rid=802263&cid=t_140309_122_f&fid=35055&url=http%3A%2F%2Fsarasotaneurology.com%2F2007%2F08%2F16%2Fnew-treatment-options-for-parkinsons-disease%2F The FDA has approved a new medication therapy for the treatment of Parkinson’s disease. The new drug is rotigotine, which is in the family of dopamine agonists. Dopamine agonists mimic the effects of levodopa (Sinemet) without having to go through chemical transformation. Other dopamine agonists include Mirapex and Requip. Rotigotine (Neupro) is different in that it comes in the form of a patch. This has the advantage that the medication is delivered continuously through the skin, while you are wearing the patch. Theoretically, this would provide a more even blood concentration of medication throughout the day. Patients using Neupro should not be taking one of the other dopamine agonists. This patch can be used alone or in combination with other Parkinson medications, to help improve... Sarasota Neurology blogs http://www.medworm.com/rss/comments.php?id=802263 Thu, 16 Aug 2007 11:06:03 +0100 802263